Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 17.6 M4.43 M7.45 M-20.66 M 8.83 M Research & development ———— — Operating income 86.48 M92.03 M124.24 M123.7 M 426.46 M Non-Operating Income, Total -9.16 M-3.24 M-4.32 M-12.2 M -28.92 M Interest expense, net of interest capitalized 11.31 M12.18 M14.14 M— — Non-Operating Income, excl. Interest Expenses -10.96 M-12.03 M-14.53 M-476 K -38 M Unusual income/expense -9.51 M-3.38 M-3.94 M-11.73 M -28.55 M Pretax income 65.66 M76.48 M106.16 M99.11 M 347.41 M Equity in earnings ———— — Taxes 8.2 M8.05 M15.79 M21.81 M 53.85 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 57.46 M68.43 M90.37 M77.3 M 293.56 M Discontinued operations ———— — Net income 57.46 M68.43 M90.37 M77.3 M 293.56 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 57.46 M68.43 M90.37 M77.3 M 293.56 M Basic earnings per share (Basic EPS) 1.481.832.452.08 7.84 Diluted earnings per share (Diluted EPS) 1.461.82.42.04 7.7 Average basic shares outstanding 38.8 M37.44 M36.86 M37.44 M — Diluted shares outstanding 39.3 M37.98 M37.66 M38.14 M — EBITDA ——801 M981.87 M — EBIT 732.14 M787.26 M771.32 M927.81 M 3.22 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ——29.68 M54.06 M —